Bristol-Myers Squibb
BMY
40,02 €
Share price
-1.93%
Change (1 day)
8.66%
Change (1 year)
Categories
Market capitalization of Bristol-Myers Squibb (BMY)
Market cap: €81.44 Billion
As of July 2025 Bristol-Myers Squibb has a market cap of €81.44 Billion. This makes Bristol-Myers Squibb the world's 209th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bristol-Myers Squibb from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €81.44 B | -27.56% |
| 2024 | €112.41 B | 19.03% |
| 2023 | €94.44 B | -33.78% |
| 2022 | €142.61 B | 16.7% |
| 2021 | €122.20 B | 7.23% |
| 2020 | €113.96 B | -10.73% |
| 2019 | €127.66 B | 73.01% |
| 2018 | €73.79 B | -11.72% |
| 2017 | €83.59 B | -9.97% |
| 2016 | €92.85 B | -11.15% |
| 2015 | €104.50 B | 30.25% |
| 2014 | €80.23 B | 27.03% |
| 2013 | €63.15 B | 57.26% |
| 2012 | €40.15 B | -12.66% |
| 2011 | €45.98 B | 35.95% |
| 2010 | €33.82 B | 12.3% |
| 2009 | €30.11 B | -8.52% |
| 2008 | €32.92 B | -8.17% |
| 2007 | €35.85 B | -8.39% |
| 2006 | €39.13 B | 3.09% |
| 2005 | €37.96 B | 3.24% |
| 2004 | €36.77 B | -16.56% |
| 2003 | €44.06 B | 1.86% |
| 2002 | €43.26 B | -61.82% |
| 2001 | €113.31 B | -26.1% |
| 2000 | €153.32 B | 21.35% |
| 1999 | €126.35 B | 12.68% |
| 1998 | €112.13 B | 41.58% |
| 1997 | €79.19 B | 72.32% |
| 1996 | €45.95 B |
End of Day market cap according to different sources
On Jul 14th, 2025 the market cap of Bristol-Myers Squibb was reported to be:
€83.04 Billion
€83.04 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €120.53 B | 48.00% | 🇺🇸 USA |
 Merck MRK | €176.87 B | 117.18% | 🇺🇸 USA |
 Eli Lilly LLY | €597.67 B | 633.88% | 🇺🇸 USA |
 Novartis NVS | €203.86 B | 150.32% | 🇨🇭 Switzerland |
 Sanofi SNY | €100.97 B | 23.98% | 🇫🇷 France |
 AstraZeneca AZN | €188.04 B | 130.90% | 🇬🇧 UK |
 Johnson & Johnson JNJ | €322.15 B | 295.58% | 🇺🇸 USA |
 AbbVie ABBV | €284.15 B | 248.91% | 🇺🇸 USA |
 Amgen AMGN | €135.80 B | 66.76% | 🇺🇸 USA |
 Biogen BIIB | €16.15 B | -80.17% | 🇺🇸 USA |